Aclaris Therapeutics Inc (ACRS) stock news · rev $3.6M
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
This ACRS news page leads with what Aclaris Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ACRS yet. We will not pad this page with generic market recap.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ACRS stock page; for the tape open the quote page.
Not investment advice.